In this important piece at @ehj_ed#EHJ@ATycinska and @escardio nominating committee (where I was honoured to be a part of) emphasize the shortage of applications by female colleagues for ESC leadership positions ➡️ https://t.co/8HqTDVA5E7
🔥”The problem extends beyond leadership in professional societies and permeates the entire academic and clinical career pathway. Without targeted, measurable action, the gap will persist across generations of cardiologists. Tackling these systemic challenges requires coordinated, sustained, and accountable efforts from institutions, scientific societies, and individual leaders”
🔥 “To women colleagues at all career stages, we send a clear and unequivocal message: your expertise, perspectives, and lived experience are essential to the future of our Society and to the advancement of cardiovascular care in Europe. Your voice is needed not only at the bedside but also in decision-making” @Antonia_Sambola@weidinger_franz@EmmaSvennberg@OliviaManfrini@LindeCecilia@mrubini@WomenAs1
🌍 A great opportunity!
The @escardio WG on Coronary Pathophysiology & Microcirculation Mobility Travel Grant is now open!
📅 Apply now 👉https://t.co/3Ubyh8uCCt
Spread the word & share w/colleagues!
#ESC#WGCPM_ESC#MTG@EdinaCenko@maria_bergami@escardio
A great discussion at #ESCCongress2026 during our session on inequalities & disparities in cardiovascular health.
Excellent presentations from @RBugiardini@maryamkavousi Antonia Sambola & @CVR_TomaszGuzik on diet, sex & gender, ethnicity & race, & hypertension
At #ESCCongress 2026 @escardio Working Group on Coronary Pathophysiology & Microcirculation invites you to explore
❤️ Non-conventional risk factors for CVD
📅 28 Aug | 08:15–09:45
📍 Chisinau, Hall B1
👉https://t.co/TRroZu6I9a
@cpgale3@EdinaCenko@maria_bergami#WGCPM_ESC
At #ESCCongress 2026, @escardio WG on Coronary Pathophysiology & Microcirculation invites yuo to join:
🫀 Leave nothing behind: fact or fiction?
📅 29 Aug | 08:15–09:45
📍 Bratislava, ICM
👉https://t.co/v6H3KOx9hV
@EdinaCenko@maria_bergami#WGCPM_ESC#ESC
💔 Why do heart attack patients with NO traditional risk factors face higher short-term mortality?
This "paradox" likely reflects index-event & dilution bias
Congrats to all co-authors! 👏
👇
https://t.co/9cTXhhGvs0
@EdinaCenko@maria_bergami@RBugiardini@ATHjournal
❤️ What's New in Prediction and Prevention of Cardiovascular Complications in Diabetes?
Still a few seats left!
👉Free and open to all. Register now: https://t.co/QuHoSmPuLE
@EdinaCenko@WGCPMChair@ESCWGAVBChair@escardio#WGCPM_ESC
❤️ What's New in Prediction and Prevention of Cardiovascular Complications in Diabetes?
Still a few seats left!
Join us on 18 June 2026, 16:00–17:00 CEST
🎓 Free and open to all. Register now:
https://t.co/QuHoSmPuLE
🫀Despite successful primary PCI MVO occurs in up to 60% of #STEMI pts & remains a key driver of HF & mortality
Read the new #ESC Clinical Consensus Statement on the Pathophysiology Prevention & Management of Coronary MVO
👉https://t.co/1ej9m0H6du
@EdinaCenko@ehj_ed@escardio
Coronary microvascular obstruction: the "no-reflow" problem that haunts STEMI care. New ESC clinical consensus on pathophysiology, prevention & management: a must-read. Read more in #EHJ.
https://t.co/WWlcFSfVyj
#cardiotwitter@ESC_Journals@escardio
Does physician sex influence CV outcomes?
This article reviews evidence suggesting outcome differences may exist across settings, highlighting possible links to communication, guideline use, and care delivery, while noting the complexity of causality.
https://t.co/c7LGXK9GGN
Rethink beta-blockers for uncomplicated hypertension?
Our @HyperAHA commentary: despite guideline upgrades evidence for routine use in uncomplicated cases is limited
👉 https://t.co/VJmEEBcKqM
Rethink beta-blockers for uncomplicated hypertension?
Our @HyperAHA commentary: despite guideline upgrades evidence for routine use in uncomplicated cases is limited
👉 https://t.co/VJmEEBcKqM